Peer-Reviewed Journal Articles Rosen, C.A., J. Gartner- Schmidt,(et al.), “Vocal fold augmentation with calcium hydroxylapatite (CaHA). Otolaryngology—Head and Neck Surgery (2007) 136, 198-204.
Rosen, C.A., J. Gartner- Schmidt,(et al.), “Vocal fold augmentation with calcium hydroxylapatite (CaHA): Twelve month report. Presented on May 19, 2006 at the Annual Meeting of the American Bronco-Esophageal Association, Chicago, IL.
Rosen, Clark A. (et al.), “Vocal Fold Augmentation with Injectable Calcium Hydroxylapatite: Short-Term Results.” Journal of Voice, September 2004, Vol. 18, No. 3. p. 387-391.
Belafsky, Peter C. (et al.), “Vocal Fold Augmentation with Calcium Hydroxyapatite.” Otolaryngology – Head and Neck Surgery, October 2004, Vol. 131, No. 3, p. 351-354.
Chhetri, Dinesh K. (et al.), “Injection Laryngoplasty with Calcium Hydroxylapatite Gel Implant in an In-Vivo Canine Model.” Annals of Otology, Rhinology & Laryngology, April 2004, Vol. 113, No. 4, p. 259-264.
Hughes, Richard G. M., “Vocal Cord Medialization by Transcutaneous Injection of Calcium Hydroxylapatite.” Journal of Voice, December 2005, Vol. 19, No. 4, p. 674-678.
Kwon, T. K. (et al.), “Preliminary Results of a New Temporary Vocal Fold Injection Material.” Journal of Voice, December 2005, Vol. 19, No. 4, p. 668-673.
White Papers on Injection Techniques Rosen, Clark A. “Performing RADIESSE® Trans-Oral Vocal Fold Augmentation Injection via Flexible Nasopharyngoscopic Guidance and Drip Laryngeal Anesthesia: Tips and Pearls.”
Important RADIESSE® VOICE and RADIESSE® Voice Gel Treatment Considerations
RADIESSE® Voice and RADIESSE® Voice Gel are FDA-cleared for vocal fold augmentation and vocal fold insufficiency associated with serious aspiration disorders. After injection, patients may experience transient throat soreness, bruising, swelling, or other local side effects. More rare side effects may include over-injection or under-injection that may require repeated intervention, and as with any injection there may be a risk of infection.